Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cass

Showing results (21-30 of 178) with videos related to

Pageof 18
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 10, 1999
GDNF protection against 6-OHDA-induced reductions in potassium-evoked overflow of striatal dopamineW A Cass, M W Manning
Neuroscience|November 18, 2006
Oxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of Parkinson's diseaseM P Smith, W A Cass
Neuroscience Letters|August 1, 1994
Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptakeW A Cass, G A Gerhardt
The Journal of General Physiology|July 1, 1970
The ion permeability induced in thin lipid membranes by the polyene antibiotics nystatin and amphotericin BA Cass, A Finkelstein, V Krespi
Oncogene|March 7, 2000
Ras signaling through PI3K confers hormone-independent proliferation that is compatible with differentiationL A Cass, J L Meinkoth
Neuroscience Letters|November 28, 2006
GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's diseaseMichael P Smith, Wayne A Cass
Investigative Urology|January 1, 1973
Bacteriuria in intestinal cconduit urinary diversion in dogsB Spence, J Esho, A Cass
Neurochemistry International|August 3, 2023
Calcitriol protects against reductions in striatal serotonin in rats treated with neurotoxic doses of methamphetamineWayne A Cass, Laura E Peters
Endocrinology|April 7, 1998
Differential effects of cyclic adenosine 3',5'-monophosphate on p70 ribosomal S6 kinaseL A Cass, J L Meinkoth
Synapse (New York, N.Y.)|January 1, 1990
Inhibition of striatal dopamine release by the selective D-2 dopamine receptor agonist N-0437 is blocked by quinineW A Cass, N R Zahniser
Pageof 18

Showing results (21-30 of 178) with videos related to

Sort By:
Pageof 18
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 10, 1999
GDNF protection against 6-OHDA-induced reductions in potassium-evoked overflow of striatal dopamineW A Cass, M W Manning
Neuroscience|November 18, 2006
Oxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of Parkinson's diseaseM P Smith, W A Cass
Neuroscience Letters|August 1, 1994
Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptakeW A Cass, G A Gerhardt
The Journal of General Physiology|July 1, 1970
The ion permeability induced in thin lipid membranes by the polyene antibiotics nystatin and amphotericin BA Cass, A Finkelstein, V Krespi
Oncogene|March 7, 2000
Ras signaling through PI3K confers hormone-independent proliferation that is compatible with differentiationL A Cass, J L Meinkoth
Neuroscience Letters|November 28, 2006
GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's diseaseMichael P Smith, Wayne A Cass
Investigative Urology|January 1, 1973
Bacteriuria in intestinal cconduit urinary diversion in dogsB Spence, J Esho, A Cass
Neurochemistry International|August 3, 2023
Calcitriol protects against reductions in striatal serotonin in rats treated with neurotoxic doses of methamphetamineWayne A Cass, Laura E Peters
Endocrinology|April 7, 1998
Differential effects of cyclic adenosine 3',5'-monophosphate on p70 ribosomal S6 kinaseL A Cass, J L Meinkoth
Synapse (New York, N.Y.)|January 1, 1990
Inhibition of striatal dopamine release by the selective D-2 dopamine receptor agonist N-0437 is blocked by quinineW A Cass, N R Zahniser
Pageof 18